June 1 (Reuters) - Moderna MRNA.O said on Monday it has expanded its tie up with the Coalition for Epidemic Preparedness Innovations to advance the development of a potential vaccine against Bundibugyo ebolavirus.

Under the agreement, CEPI has committed up to $50 million to support preclinical development and early clinical testing of Moderna's investigational BDBV vaccine candidate, Moderna said.